Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012:2012:926931.
doi: 10.1155/2012/926931. Epub 2012 Jul 16.

Systemic lupus erythematosus: genomics, mechanisms, and therapies

Editorial

Systemic lupus erythematosus: genomics, mechanisms, and therapies

Antonio Fernández-Nebro et al. Clin Dev Immunol. 2012.
No abstract available

PubMed Disclaimer

Similar articles

Cited by

References

    1. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15(5):308–318. - PubMed
    1. Kyogoku C, Dijstelbloem HM, Tsuchiya N, et al. Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis and Rheumatism. 2002;46(5):1242–1254. - PubMed
    1. Li X, Wu J, Carter RH, et al. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis and Rheumatism. 2003;48(11):3242–3252. - PubMed
    1. Patole PS, Gröne HJ, Segerer S, et al. Viral double-stranded RNA aggravates lupus nephritis through toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. Journal of the American Society of Nephrology. 2005;16(5):1326–1338. - PubMed
    1. Horton CG, Pan ZJ, Farris AD. Targeting toll-like receptors for treatment of SLE. Mediators of Inflammation. 2010;2010498980 - PMC - PubMed

Publication types

MeSH terms